Le Lézard
Classified in: Business
Subject: INO

Thinking about buying stock in Exicure, Yellow Corp, Senseonics, Global Blood Therapeutics, or Motus GI?


NEW YORK, Aug. 4, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for XCUR, YELL, SENS, GBT, and MOTS.

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

 

SOURCE InvestorsObserver


These press releases may also interest you

at 06:15
United Microelectronics Corporation ("UMC" or "The Company"), a leading global semiconductor foundry, today announced its consolidated operating results for the first quarter of 2024. First quarter consolidated revenue was NT$54.63 billion,...

at 06:13
Synchrony Financial today announced its first quarter 2024 results for the period ending March 31, 2024. The earnings news release, financial tables and related materials can be found on the company's investor relations website...

at 06:05
Hilton Worldwide Holdings Inc. ("Hilton," "the Company," "we," "us" or "our") today reported its first quarter 2024 results. Highlights include: Diluted EPS was $1.04 for the first quarter, and diluted EPS, adjusted for special items, was $1.53...

at 06:05
Summit Bank Group Q1 2024 Net Income - $2.4 million or $0.31 per fully diluted share. Q1 2024 Net Income increased from $0.30 per share for Q1 2023 and $0.22 per share for Q4 2023. Cash and Securities totaled $149.9 million ? 13.0 percent...

at 06:05
Thermo Fisher Scientific Inc. , the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2024. First Quarter 2024 Highlights First quarter revenue was $10.34 billion. First quarter GAAP...

at 06:05
Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced today that it will release financial results for the first quarter ended March 31, 2024 after the close of trading on Wednesday, May 8. Biodesix's...



News published on and distributed by: